Hemophagocytic lymphohistiocytosis: A concise review for the practicing physician

Allergy and Asthma Proceedings

Volumn 37, Issue 3, 2016, Pages 256-258

  Sifers, Travis M ^a   Raje, Nikita ^b   Dinakar, Chitra ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; ETOPOSIDE; FERRITIN; GAMMA INTERFERON; GRANZYME; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR ALPHA; METHOTREXATE; PERFORIN; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ARTICLE; CYTOKINE RELEASE; CYTOPENIA; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS INFECTION; ERYTHROPHAGOCYTOSIS; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPERFERRITINEMIA; HYPERTRIGLYCERIDEMIA; HYPOFIBRINOGENEMIA; MACROPHAGE ACTIVATION SYNDROME; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PLASMAPHERESIS; SPLENOMEGALY; SURVIVAL RATE; DISEASE MANAGEMENT; PHYSICIAN;

DISEASE MANAGEMENT; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; PHYSICIANS;

EID: 84968546903     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2016.37.3948     Document Type: Article

References (18)

1. Frieri MB, Beck G, Cardenas P, et al. Immunomodulation in an infant with familial hemophagocytic lymphohistiocytosis following chemotherapy. Ped Asthma Allergy Immunol 14:239-247, 2000.
2. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med 63:233-246, 2012.
3. Brisse E, Wouters CH, and Matthys P. Hemophagocytic lymphohistiocytosis (HLH): A heterogeneous spectrum of cytokinedriven immune disorders. Cytokine Growth Factor Rev 26:263-280, 2015.
4. Mehta RS, and Smith RE. Hemophagocytic lymphohistiocytosis (HLH): A review of literature. Med Oncol 30:740, 2013.
5. Henter JI, Elinder G, Soder O, and Ost A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 80:428-435, 1991.
6. George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med 5:69-86, 2014.
7. Fitzgerald NE, and MacClain KL. Imaging characteristics of hemophagocytic lymphohistiocytosis. Pediatr Radiol 33:392-401, 2003.
8. Frieri MS, Beck G, Kumar K, et al. Role of harmful molecules in the pathogenesis of sepsis: A review J Nat Sci 1:e142, 2015.
9. Molleran Lee S, Villanueva J, Sumegi J, et al. Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis. J Med Genet 41:137-144, 2004.
10. Kasahara Y, and Yachie A. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Crit Rev Oncol Hematol 44:283-294, 2002.
11. Grom AA, Villanueva J, Lee S, et al. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 142:292-296, 2003.
12. Zhang M, Behrens EM, Atkinson TP, et al. Genetic defects in cytolysis in macrophage activation syndrome. Curr Rheumatol Rep 16:439, 2014.
13. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 140:221-230, 1983.
14. Henter JI, Horne A, Arico M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124-131, 2007.
15. Trottestam H, Horne A, Arico M, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: Long-term results of the HLH-94 treatment protocol. Blood 118:4577-4584, 2011.
16. Demirkol D, Yildizdas D, Bayrakci B, et al. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: What is the treatment? Crit Care 16:R52, 2012.
17. Rajasekaran S, Kruse K, Kovey K, et al. Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children∗. Pediatr Crit Care Med 15:401-408, 2014.
18. Allen CE, Yu X, Kozinetz CA, and McClain KL. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 50:1227-1235, 2008.